Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
AntiCD20+ Agents - Practical Neurology
Mechanisms of killing by anti-CD20 monoclonal antibodies - ScienceDirect
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Lymphoma: Radioimmunotherapy Using Iodine-131 Labeled Murine Anti-CD20 Antibodies (131I-Tositumomab and Tositumomab, “Bexxar”) | Radiology Key
Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis - touchNEUROLOGY
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | SpringerLink
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Anti-tumor antibody (anti-CD20)-opsonized tumor cells (A) and... | Download Scientific Diagram
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | SpringerLink
Treatment of multiple sclerosis with anti-CD20 antibodies. | Semantic Scholar
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease | PNAS
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
CD20 - Wikipedia
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
The effects of type I and type II anti-CD20 mAb binding to CD20 on... | Download Scientific Diagram
